Viskase Holdings, Inc. (ENZN)
Viskase Holdings, Inc. is a common stock listing on OTC Markets. The company currently has no significant operations. In the past, it was involved in selling its drug product, PegIntron. The business was originally incorporated in 1981 and adopted the Enzon Pharmaceuticals, Inc. name in December 2002. The company is headquartered in Cranford, New Jersey.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ENZN
|
$5.26
|
22.9% Upside
|
Undervalued
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 3, 2026
|
-1.0x
|
0.3x
|
0.2x
|
61.339 M
|
182.7 M
|
71.8%
|
99.9%
|
1.1
|
—
|
69.0%
|